- 5 February 2015
- book chapter
- Published by Springer Nature
- p. 99-108
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Adjuvant Trastuzumab in HER2-Positive Breast CancerNew England Journal of Medicine, 2011
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31Journal of Clinical Oncology, 2011
- Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)Breast Cancer Research and Treatment, 2011
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breastCancer, 2010
- Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breastEuropean Journal of Cancer, 2003
- p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breastEuropean Journal of Cancer, 1997
- Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breastEuropean Journal of Cancer, 1996
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987